» Articles » PMID: 33673707

Lutein Exerts Antioxidant and Anti-Inflammatory Effects and Influences Iron Utilization of BV-2 Microglia

Overview
Date 2021 Mar 6
PMID 33673707
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Lutein is a tetraterpene carotenoid, which has been reported as an important antioxidant and it is widely used as a supplement. Oxidative stress participates in many human diseases, including different types of neurodegenerative disorders. Microglia, the primary immune effector cells in the central nervous system, are implicated in these disorders by producing harmful substances such as reactive oxygen species (ROS). The protective mechanisms which scavenge ROS include enzymes and antioxidant substances. The protective effects of different carotenoids against oxidative stress have been described previously. Our study focuses on the effects of lutein on antioxidant enzymes, cytokines and iron metabolism under stress conditions in BV-2 microglia. We performed cell culture experiments: BV-2 cells were treated with lutein and/or with HO; the latter was used for inducing oxidative stress in microglial cells. Real-time PCR was performed for gene expression analyses of antioxidant enzymes, and ELISA was used for the detection of pro- and anti-inflammatory cytokines. Our results show that the application of lutein suppressed the HO-induced ROS (10': 7.5 ng + 10 µM HO = 0.0002; 10 ng/µL + 10 µM HO = 0.0007), influenced iron utilization and changed the anti-inflammatory and pro-inflammatory cytokine secretions in BV-2 cells. Lutein increased the IL-10 secretions compared to control (24 h: 7.5 ng/µL = 0.0274; 10 ng/µL = 0.0008) and to 10 µM HO-treated cells (24 h: 7.5 ng/µL + HO = 0.0003; 10 ng/µL + HO = 0.0003), while it decreased the TNFα secretions compared to HO treated cells (24 h: 7.5 ng/µL + HO < 0.0001; 10 ng/µL + HO < 0.0001). These results contribute to understanding the effects of lutein, which may help in preventing or suppressing ROS-mediated microglia activation, which is related to neuronal degeneration in oxidative stress scenario.

Citing Articles

E2F1/CDK5/DRP1 axis mediates microglial mitochondrial division and autophagy in the pathogenesis of cerebral ischemia-reperfusion injury.

Yuan Y, Chen T, Yang Y, Han H, Xu L Clin Transl Med. 2025; 15(2):e70197.

PMID: 39968698 PMC: 11836619. DOI: 10.1002/ctm2.70197.


Clinical rationale for dietary lutein supplementation in long COVID and mRNA vaccine injury syndromes.

Kyriakopoulos A, Nigh G, McCullough P, Seneff S F1000Res. 2024; 13:191.

PMID: 39526116 PMC: 11549548. DOI: 10.12688/f1000research.143517.3.


Effects and Mechanisms of Lutein on Aging and Age-Related Diseases.

Ye J, Cheng J, Xiong R, Chen H, Huang S, Li H Antioxidants (Basel). 2024; 13(9).

PMID: 39334773 PMC: 11428584. DOI: 10.3390/antiox13091114.


Lutein inhibits glutamate-induced apoptosis in HT22 cells via the Nrf2/HO-1 signaling pathway.

Li Z, Cao Z, Chen F, Li B, Jin H Front Neurosci. 2024; 18:1432969.

PMID: 39193525 PMC: 11347311. DOI: 10.3389/fnins.2024.1432969.


P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy.

Fan Z, Wang K, Zhao X, Sun X Open Life Sci. 2024; 19(1):20220775.

PMID: 38585633 PMC: 10998679. DOI: 10.1515/biol-2022-0775.


References
1.
Donegan R, Moore C, Hanna D, Reddi A . Handling heme: The mechanisms underlying the movement of heme within and between cells. Free Radic Biol Med. 2018; 133:88-100. PMC: 6363905. DOI: 10.1016/j.freeradbiomed.2018.08.005. View

2.
Paul B, Manz D, Torti F, Torti S . Mitochondria and Iron: current questions. Expert Rev Hematol. 2016; 10(1):65-79. PMC: 5538026. DOI: 10.1080/17474086.2016.1268047. View

3.
Li F, Nikali K, Gregan J, Leibiger I, Leibiger B, Schweyen R . Characterization of a novel human putative mitochondrial transporter homologous to the yeast mitochondrial RNA splicing proteins 3 and 4. FEBS Lett. 2001; 494(1-2):79-84. DOI: 10.1016/s0014-5793(01)02319-5. View

4.
Wang W, Tan M, Yu J, Tan L . Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Ann Transl Med. 2015; 3(10):136. PMC: 4486922. DOI: 10.3978/j.issn.2305-5839.2015.03.49. View

5.
Harms A, Lee J, Nguyen T, Chang J, Ruhn K, Trevino I . Regulation of microglia effector functions by tumor necrosis factor signaling. Glia. 2011; 60(2):189-202. PMC: 3232308. DOI: 10.1002/glia.21254. View